Betatrophin Acts as a Diagnostic Biomarker in Type 2 Diabetes Mellitus and Is Negatively Associated with HDL-Cholesterol

Table 2

Correlations between betatrophin levels and various parameters of the study subjects.

Variables	Overall	NDM	T2DM
Age (years)	;	;	;
BMI (kg/m^2)	;	;	;
WHR	;	;	;
Fasting glucose (mM)	;	;	;
Fast insulin (mIU/L)	;	;	;
C peptide (g/L)	;	;	;
HOMA-IR	;	;	;
HOMA-%	;	;	;
QUICKI	;	;	;
TC (mM)	;	;	;
TG (mM)	;	;	;
LDL-C (mM)	;	;	;
HDL-C (mM)	;	;	;
Uric acid (mol/L)	;	;	;
ALT (IU/L)	;	;	;
AST (IU/L)	;	;	;

BMI: body mass index; WHR: waist-to-hip ratio; FINS: fasting blood insulin; FBG: fasting blood glucose; HOMA-IR: homeostasis model assessment of insulin resistance; HOMA-%: homeostasis model assessment of cell function; TC: total cholesterol; TG: triglyceride; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; QUICKI: Quantitative Insulin Sensitivity Check Index; ALT: alanine aminotransferase; AST: aspartate aminotransferase; NAFLD: nonalcoholic fatty liver disease.
.